You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恒指季檢結果公佈!恒指成分股不變,海倫司等41股遭剔除恒生綜合指數

2月21日,恒生指數有限公司(恒生指數公司)宣佈截至2024年12月31日之恒生指數系列季度檢討結果,所有變動將於2025年3月10日(星期一)起生效 。

恒指成份股數目維持83只未變

科指、國指稍有變動

根據恒生指數公司公吿,恒指成分股未發生變動,成份股數目維持83只。

恒生科技指數調入騰訊音樂、地平線機器人,剔除東方甄選、眾安在線,成份股數目維持30只。

恒生中國企業指數調入中通快遞、百濟神州,剔除中國生物製藥、李寧,成份股數目維持50只。

此外,恒生生物科技指數成份股數目維持 50 只。先健科技公司獲加入,宜明昂科遭剔除。

恒生綜指成份股調整:納入29只,剔除41只

恒生綜合指數出現較大變動成份股數目由517只減少至505只。其中,訊飛醫療首程控股、多點數智等29股獲納入,海倫司、奈雪的茶、旭輝控股、來凱醫藥等41股遭剔除。

根據港股通的調整規則,恒生綜合指數成份股的變動將影響港股通可投資證券的調整。

在本次調整的標的中,上海石油化工股份、上海復旦、泰格醫藥、康龍化成、港股通可投資標的。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account